Cargando…
Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma
N6-methyladenosine (m(6)A), the most abundant internal RNA modification, serves a critical role in cancer development. However, the clinical implications of m(6)A in hepatocellular carcinoma (HCC) remain unclear. The present study sought to reveal the potential roles of m(6)A readers, which recogniz...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161462/ https://www.ncbi.nlm.nih.gov/pubmed/34084217 http://dx.doi.org/10.3892/ol.2021.12799 |
_version_ | 1783700517200855040 |
---|---|
author | Nakagawa, Nobuhiko Sonohara, Fuminori Tanaka, Katsuhito Sunagawa, Yuki Inokawa, Yoshikuni Takami, Hideki Hayashi, Masamichi Yamada, Suguru Kanda, Mitsuro Tanaka, Chie Nakayama, Goro Koike, Masahiko Kodera, Yasuhiro |
author_facet | Nakagawa, Nobuhiko Sonohara, Fuminori Tanaka, Katsuhito Sunagawa, Yuki Inokawa, Yoshikuni Takami, Hideki Hayashi, Masamichi Yamada, Suguru Kanda, Mitsuro Tanaka, Chie Nakayama, Goro Koike, Masahiko Kodera, Yasuhiro |
author_sort | Nakagawa, Nobuhiko |
collection | PubMed |
description | N6-methyladenosine (m(6)A), the most abundant internal RNA modification, serves a critical role in cancer development. However, the clinical implications of m(6)A in hepatocellular carcinoma (HCC) remain unclear. The present study sought to reveal the potential roles of m(6)A readers, which recognize m(6)A, in HCC. A total of 177 HCC and paired non-cancerous liver tissues from patients who underwent hepatectomy were analysed using quantitative PCR for the expression of m(6)A readers: YT521-B homology domain family 1 (YTHDF1) and YT521-B homology domain family 2 (YTHDF2). The expression levels of both YTHDF1 and YTHDF2 were not significantly different between tumour and non-cancerous tissues (P=0.93 and P=0.7, respectively). Analysis of the association between clinical features and m(6)A reader expression revealed that YTHDF1 expression was associated with formation of capsule (P=0.02), whereas low YTHDF2 expression was associated with septal formation (P=0.02). Furthermore, high YTHDF1 expression and high YTHDF2 expression were significantly associated with shorter recurrence-free survival (RFS) [YTHDF1: Mean survival time (MST), 34.0 vs. 19.0 months, P=0.014; YTHDF2: MST, 30.1 vs. 12.9 months, P=0.0032], whereas YTHDF1 and YTHDF2 expression was not significantly associated with overall survival (OS) (YTHDF1: MST, 99.4 vs. 70.2 months, P=0.74; YTHDF2: MST, 98.4 vs. 64.1 months, P=0.28). According to multivariate analysis, serosal invasion [hazard ratio (HR), 2.39; 95% CI 1.30–4.42; P=0.005), portal vein or hepatic vein invasion (HR, 2.82; 95% CI 1.26–6.28; P=0.01) and YTHDF2 expression in HCC tissues (HR, 1.85; 95% CI 1.09–3.15; P=0.02) were identified as significant independent prognostic factors for RFS. α-fetoprotein (HR, 1.79; 95% CI 1.10–2.92; P=0.02), serosal invasion (HR, 1.99; 95% CI 1.17–3.34; P=0.01) and portal vein or hepatic vein invasion (HR, 3.02; 95% CI 1.38–6.61; P=0.006) were identified as significant independent prognostic factors for OS. In conclusion, the present study revealed that high YTHDF2 expression, an m(6)A reader, in HCC tissues was associated with cancer recurrence. |
format | Online Article Text |
id | pubmed-8161462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-81614622021-06-02 Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma Nakagawa, Nobuhiko Sonohara, Fuminori Tanaka, Katsuhito Sunagawa, Yuki Inokawa, Yoshikuni Takami, Hideki Hayashi, Masamichi Yamada, Suguru Kanda, Mitsuro Tanaka, Chie Nakayama, Goro Koike, Masahiko Kodera, Yasuhiro Oncol Lett Articles N6-methyladenosine (m(6)A), the most abundant internal RNA modification, serves a critical role in cancer development. However, the clinical implications of m(6)A in hepatocellular carcinoma (HCC) remain unclear. The present study sought to reveal the potential roles of m(6)A readers, which recognize m(6)A, in HCC. A total of 177 HCC and paired non-cancerous liver tissues from patients who underwent hepatectomy were analysed using quantitative PCR for the expression of m(6)A readers: YT521-B homology domain family 1 (YTHDF1) and YT521-B homology domain family 2 (YTHDF2). The expression levels of both YTHDF1 and YTHDF2 were not significantly different between tumour and non-cancerous tissues (P=0.93 and P=0.7, respectively). Analysis of the association between clinical features and m(6)A reader expression revealed that YTHDF1 expression was associated with formation of capsule (P=0.02), whereas low YTHDF2 expression was associated with septal formation (P=0.02). Furthermore, high YTHDF1 expression and high YTHDF2 expression were significantly associated with shorter recurrence-free survival (RFS) [YTHDF1: Mean survival time (MST), 34.0 vs. 19.0 months, P=0.014; YTHDF2: MST, 30.1 vs. 12.9 months, P=0.0032], whereas YTHDF1 and YTHDF2 expression was not significantly associated with overall survival (OS) (YTHDF1: MST, 99.4 vs. 70.2 months, P=0.74; YTHDF2: MST, 98.4 vs. 64.1 months, P=0.28). According to multivariate analysis, serosal invasion [hazard ratio (HR), 2.39; 95% CI 1.30–4.42; P=0.005), portal vein or hepatic vein invasion (HR, 2.82; 95% CI 1.26–6.28; P=0.01) and YTHDF2 expression in HCC tissues (HR, 1.85; 95% CI 1.09–3.15; P=0.02) were identified as significant independent prognostic factors for RFS. α-fetoprotein (HR, 1.79; 95% CI 1.10–2.92; P=0.02), serosal invasion (HR, 1.99; 95% CI 1.17–3.34; P=0.01) and portal vein or hepatic vein invasion (HR, 3.02; 95% CI 1.38–6.61; P=0.006) were identified as significant independent prognostic factors for OS. In conclusion, the present study revealed that high YTHDF2 expression, an m(6)A reader, in HCC tissues was associated with cancer recurrence. D.A. Spandidos 2021-07 2021-05-19 /pmc/articles/PMC8161462/ /pubmed/34084217 http://dx.doi.org/10.3892/ol.2021.12799 Text en Copyright: © Nakagawa et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Nakagawa, Nobuhiko Sonohara, Fuminori Tanaka, Katsuhito Sunagawa, Yuki Inokawa, Yoshikuni Takami, Hideki Hayashi, Masamichi Yamada, Suguru Kanda, Mitsuro Tanaka, Chie Nakayama, Goro Koike, Masahiko Kodera, Yasuhiro Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma |
title | Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma |
title_full | Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma |
title_fullStr | Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma |
title_full_unstemmed | Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma |
title_short | Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma |
title_sort | novel prognostic implications of yth domain family 2 in resected hepatocellular carcinoma |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161462/ https://www.ncbi.nlm.nih.gov/pubmed/34084217 http://dx.doi.org/10.3892/ol.2021.12799 |
work_keys_str_mv | AT nakagawanobuhiko novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma AT sonoharafuminori novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma AT tanakakatsuhito novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma AT sunagawayuki novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma AT inokawayoshikuni novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma AT takamihideki novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma AT hayashimasamichi novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma AT yamadasuguru novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma AT kandamitsuro novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma AT tanakachie novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma AT nakayamagoro novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma AT koikemasahiko novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma AT koderayasuhiro novelprognosticimplicationsofythdomainfamily2inresectedhepatocellularcarcinoma |